STOCK TITAN
  1. Home
  2. Sec-filings
  3. GTBP
  4. [EFFECT] GT Biopharma Inc. SEC Filing

[EFFECT] GT Biopharma Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 2, 2025 5:00 P.M.
Form: S-1
CIK: 0000109657
Company Name: GT Biopharma, Inc.
File Number: 333-287963

Source: View Original Filing on SEC EDGAR

Stock GTBP logo
Gt Biopharma Inc

NASDAQ:GTBP

GTBP Rankings

#6298 Ranked by Market Cap
N/A Ranked by Dividends
#194 Top Loser

GTBP Latest News

Mar 2, 2026
GT Biopharma Reports Full Year 2025 Financial Results
Feb 17, 2026
GT Biopharma to Present at the Centurion One Capital 9th Annual Toronto Growth Conference
Feb 3, 2026
GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-5550 TriKE®, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors Expressing B7-H3
Jan 15, 2026
GT Biopharma Announces IND Submission for GTB-5550 TriKE®, a B7-H3-targeted natural killer (NK) cell engager for B7-H3 expressing solid tumor cancers
Nov 19, 2025
GT Biopharma, Inc. (NASDAQ:GTBP) Offers Near-Term Catalyst Opportunity with Advancing Phase 1 Trials

GTBP Latest SEC Filings

Mar 2, 2026
[10-K] GT Biopharma, Inc. Files Annual Report
Mar 2, 2026
[8-K] GT Biopharma, Inc. Reports Material Event
Feb 2, 2026
[EFFECT] GT Biopharma, Inc. SEC Filing
Jan 30, 2026
[424B3] GT Biopharma, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Jan 21, 2026
[S-1] GT Biopharma, Inc. Files IPO Registration Statement

GTBP Stock Data

12.45M
9.91M
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN FRANCISCO